Alto Neuroscience, Inc.
ANRO- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001999480
In the last 90 days, Alto Neuroscience, Inc. insiders filed 0 open-market purchases and 2 sales; 132 institutions reported holding it in 13F filings for Q3 2026, worth $991.9M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Alto Neuroscience, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 2 filings
- 2 insiders, $5.64M in total
- Insiders trading
- 2
- Net value
- −$5.64M
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Alto Neuroscience, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Hanley Jr. Michael Conick | CHIEF OPERATING OFFICER | 0 | Nov 18, 2026 | 2 |
| Smith Nicholas Conrad | PRESIDENT AND CFO | 79,060 | Oct 5, 2026 | 4 |
| Miller Andrew Craig | Director | – | May 29, 2026 | 1 |
| Etkin Amit | PRESIDENT AND CEO | 833,949 | May 15, 2026 | 3 |
| Dreyfus Andrew | Director | – | May 14, 2026 | 1 |
| Sanchez Ramiro | Director | – | May 14, 2026 | 2 |
| Cox Christopher Nixon | Director | 715,653Indirect | May 14, 2026 | 2 |
| York Gwill | Director | 23,917 | May 14, 2026 | 2 |
| Manji Husseini | Director | – | May 14, 2026 | 2 |
| Savitz Adam | CHIEF MEDICAL OFFICER | 39,851Indirect | Feb 13, 2026 | 1 |
| Radhakrishnan Maha | Director | – | Mar 12, 2024 | 0 |
| Apeiron Presight Capital Fund II, L.P. | Other: See Remarks | 674,658Indirect | Mar 6, 2024 | 0 |
| Apeiron Investment Group Ltd. | Other: See Remarks | 674,658Indirect | Mar 6, 2024 | 0 |
| Angermayer Christian | Other: See Remarks | 674,658Indirect | Mar 6, 2024 | 0 |
| Alpha Wave Global, LP | 10% Owner | 3,707,757Indirect | Feb 8, 2024 | 0 |
| Alpha Wave Ventures GP, Ltd | 10% Owner | 3,707,757Indirect | Feb 8, 2024 | 0 |
| Lunate Holding RSC Ltd | 10% Owner | 3,707,757Indirect | Feb 8, 2024 | 0 |
| Chimera Investment LLC | 10% Owner | 3,707,757Indirect | Feb 8, 2024 | 0 |
| Chen Po Yu (Jeff) | Director | 47,709 | Feb 7, 2024 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 18, 2026 (view filing)7:32 PM ET | Nov 16-18 | 2 days | Hanley Jr. Michael ConickCHIEF OPERATING OFFICER | SSale | −75.0K | $27.61 | −$2.07M | −100.0%0 after | 5 lots |
| Oct 1, 2026 (view filing)9:33 PM ET | Sep 29-30 | 2 days | Smith Nicholas ConradPRESIDENT AND CFO | SSale | −134.9K | $26.45 | −$3.57M | −84.9%24.1K after | 3 lots |
| Jul 11, 2024 (view filing) | Jul 9-10 | 2 days | Savitz AdamCHIEF MEDICAL OFFICER | PPurchase | +15.0K | $12.72 | +$190.8K | +60.4%39.9K after | 3 lots |
| Apr 1, 2024 (view filing) | Mar 28 | 4 days | Smith Nicholas ConradCHIEF FINANCIAL OFFICER | PPurchase | +6.15K | $16.36 | +$100.6K | +29.7%26.9K after | 2 lots |
| Feb 8, 2024 (view filing)4:32 PM ET | Feb 6 | 2 days | Alpha Wave Global, LP and 3 others10% Owner | PPurchase | +600.0K | $16.00 | +$9.60M | +19.3%3.71M after | |
| Feb 7, 2024 (view filing) | Feb 6 | 1 day | Smith Nicholas ConradCHIEF FINANCIAL OFFICER | PPurchase | +1.56K | $16.00 | +$25.0K | New position1.56K after | |
| Feb 7, 2024 (view filing) | Feb 6 | 1 day | Savitz AdamCHIEF MEDICAL OFFICER | PPurchase | +17.0K | $16.00 | +$272.0K | +216.5%24.9K after | |
| Feb 7, 2024 (view filing) | Feb 6 | 1 day | Etkin AmitPRESIDENT AND CEO | PPurchase | +3.13K | $16.00 | +$50.0K | +0.3%1.21M after |